-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of the cost of borrowed funds accounted for as interest expense.
-
Summary
-
Biomarin Pharmaceutical Inc quarterly/annual Interest Expense history and growth rate from 2010 to 2023.
- Biomarin Pharmaceutical Inc Interest Expense for the quarter ending March 31, 2024 was $3.55M, a 4.21% decline year-over-year.
- Biomarin Pharmaceutical Inc Interest Expense for the twelve months ending March 31, 2024 was $17.2M, a 8.27% increase year-over-year.
- Biomarin Pharmaceutical Inc annual Interest Expense for 2023 was $17.3M, a 8.55% increase from 2022.
- Biomarin Pharmaceutical Inc annual Interest Expense for 2022 was $16M, a 4.13% increase from 2021.
- Biomarin Pharmaceutical Inc annual Interest Expense for 2021 was $15.3M, a 47.7% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)